Patients with beta-thalassemia major (also known as Cooley's anemia) have a reduction or absence of beta protein in their ...

In late 2019, the FDA approved luspatercept-- an erythroid maturation agent administered subcutaneously every 3 weeks -- for the treatment of anemia in adults with thalassemia who require regular ...

An international research team, led by scientists from Tel Aviv University and Sheba Medical Center, has unveiled an ...

Presented positive results from the ENERGIZE-T Phase 3 randomized clinical trial evaluating mitapivat versus placebo in adults with transfusion-dependent alpha- or beta-thalassemia at the 66ᵗʰ ...

In conducting its work, the committee will examine: The epidemiology (including changing epidemiology with aging of the thalassemia population), health ... as patients transition from pediatric to ...

Discover top medications for 'treating Thalassemia'? This page compiles essential information on generic and brand-name drugs specifically used for Thalassemia treatment.Here, you can explore ...

These immortalised lines are derived from CD34 + adult stem cell samples and designed for use as ... and produce a final reticulocyte (immature red blood cell) product. Beta-thalassemia is a blood ...

After a long struggle, and with the help of Frank Vella, a biochemist from Singapore University, we found that this child had thalassemia, an inherited blood disease that was thought at the time ...

Activating stem cells via molecular programming, rather than relying on random cell transplants, significantly enhances the success of regenerative treatments.